Summary: Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the ...

Some proteins are easier to express than others. For some, just clone them into an E. coli vector and let the bacteria do the work. But for others—such as toxic proteins, membrane proteins, ...

Researchers in Japan have developed a lipocalin-based drug delivery system that dramatically increases the solubility of the anticancer drug paclitaxel and enhances tumour suppression in a breast ...

Researchers capture first-of-its-kind video of dynein–Lis1 protein interaction, supporting future drug development for neurological disorders. Our cells rely on microscopic highways and specialized ...

Understanding the best ways to get a membrane protein to its destination in a cell is crucial, and the best method to make this happen is still unclear. Cell-free systems allow for interactions ...

Proteins are the building blocks of all organisms, and protein-protein interactions are the foundation for cellular structure, metabolism, and communication. Protein-protein interactions range from ...